ATE171623T1 - Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser - Google Patents

Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser

Info

Publication number: ATE171623T1
Authority: AT; Austria
Prior art keywords: excimer laser; sodium hyaluronate; solutions containing; containing sodium; masking agents
Prior art date: 1994-12-09

Application number

AT95119025T

Other languages

English (en)

Inventor

Amalio Cantoro

Original Assignee

Chemedica Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-09

Filing date

1995-12-04

Publication date

1998-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11402853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE171623(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-12-04 Application filed by Chemedica Sa filed Critical Chemedica Sa

1998-10-15 Application granted granted Critical

1998-10-15 Publication of ATE171623T1 publication Critical patent/ATE171623T1/de

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
230000000873 masking effect Effects 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
229920000297 Rayon Polymers 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
239000000243 solution Substances 0.000 abstract 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
206010025421 Macule Diseases 0.000 abstract 1
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
238000002679 ablation Methods 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
229910001424 calcium ion Inorganic materials 0.000 abstract 1
125000002091 cationic group Chemical group 0.000 abstract 1
210000004087 cornea Anatomy 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
229910001425 magnesium ion Inorganic materials 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
239000011591 potassium Substances 0.000 abstract 1
229910001414 potassium ion Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
229910001415 sodium ion Inorganic materials 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1
230000000472 traumatic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Materials For Medical Uses (AREA)

AT95119025T 1994-12-09 1995-12-04 Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser ATE171623T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITRM940797A IT1274984B (it)	1994-12-09	1994-12-09	Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri

Publications (1)

Publication Number	Publication Date
ATE171623T1 true ATE171623T1 (de)	1998-10-15

Family

ID=11402853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95119025T ATE171623T1 (de)	1994-12-09	1995-12-04	Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser

Country Status (10)

Country	Link
US (1)	US5871772A (de)
EP (1)	EP0719559B1 (de)
JP (1)	JP4097720B2 (de)
AT (1)	ATE171623T1 (de)
CA (1)	CA2164770C (de)
DE (1)	DE69505095T2 (de)
DK (1)	DK0719559T3 (de)
ES (1)	ES2124486T3 (de)
IT (1)	IT1274984B (de)
ZA (1)	ZA9510441B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1291291B1 (it) *	1997-04-30	1999-01-07	Chemedica Sa	Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
AU2002232437A1 (en) *	2000-12-20	2002-07-01	Alcon Universal Ltd.	Ophthalmic lubricating solution adapted for use in lasik surgery
WO2002049610A2 (en) *	2000-12-20	2002-06-27	Alcon, Inc.	Ophthalmic irrigating solution adapted for use in lasik surgery
EP1256360A1 (de) *	2001-05-10	2002-11-13	Université de Liège	Hypertonisches Medikament insbesondere zur Verwendung in der Flüssigkeitstherapie
RU2005102604A (ru) *	2002-07-03	2005-09-10	Перикор Сайенс, Инк. (Us)	Композиция гиалуроновой кислоты и способы применения
EP1802357B2 (de) *	2004-10-01	2013-09-18	Menicon Singapore Pte Ltd.	Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
JP2010538703A (ja) *	2007-09-10	2010-12-16	アルコンレンゼックス，インコーポレーテッド	レーザ手術において眼へのインタフェースを提供する装置、システム及び技術
US8845624B2 (en) *	2010-06-25	2014-09-30	Alcon LexSx, Inc.	Adaptive patient interface
US9089401B2 (en)	2011-05-06	2015-07-28	Alcon Lensx, Inc.	Adjusting ophthalmic docking system
US8939967B2 (en)	2011-08-03	2015-01-27	Alcon Lensx, Inc.	Patient interface defogger
US9044304B2 (en)	2011-12-23	2015-06-02	Alcon Lensx, Inc.	Patient interface with variable applanation
US10335315B2 (en)	2013-02-01	2019-07-02	Alcon Lensx, Inc.	Bi-radial patient interface

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US4517295A (en) *	1983-02-18	1985-05-14	Diagnostic, Inc.	Hyaluronic acid from bacterial culture
US5093487A (en) *	1986-01-06	1992-03-03	Mobay Corporation	Low viscosity high molecular weight filter sterilizable hyaluronic acid
US5409904A (en) *	1984-11-13	1995-04-25	Alcon Laboratories, Inc.	Hyaluronic acid compositions and methods
IL80298A (en) *	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
EP0346467A4 (en) *	1987-12-26	1990-11-28	Kyowa Hakko Kogyo Co., Ltd.	Process for purifying hyaluronic acid
IT1247175B (it) *	1991-04-19	1994-12-12	Fidia Spa	Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5492135A (en) *	1992-09-09	1996-02-20	Devore; Dale P.	Collagen modulators for use in photoablation excimer laser keratectomy

1994
- 1994-12-09 IT ITRM940797A patent/IT1274984B/it active IP Right Grant
1995
- 1995-12-04 AT AT95119025T patent/ATE171623T1/de active
- 1995-12-04 DE DE69505095T patent/DE69505095T2/de not_active Expired - Lifetime
- 1995-12-04 EP EP95119025A patent/EP0719559B1/de not_active Expired - Lifetime
- 1995-12-04 ES ES95119025T patent/ES2124486T3/es not_active Expired - Lifetime
- 1995-12-04 DK DK95119025T patent/DK0719559T3/da active
- 1995-12-08 CA CA002164770A patent/CA2164770C/en not_active Expired - Lifetime
- 1995-12-08 JP JP34590395A patent/JP4097720B2/ja not_active Expired - Fee Related
- 1995-12-08 ZA ZA9510441A patent/ZA9510441B/xx unknown
- 1995-12-11 US US08/570,097 patent/US5871772A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH08253505A (ja)	1996-10-01
IT1274984B (it)	1997-07-29
JP4097720B2 (ja)	2008-06-11
DE69505095T2 (de)	1999-04-15
CA2164770C (en)	2008-04-22
US5871772A (en)	1999-02-16
ZA9510441B (en)	1996-06-19
ES2124486T3 (es)	1999-02-01
EP0719559B1 (de)	1998-09-30
ITRM940797A0 (it)	1994-12-09
DK0719559T3 (da)	1999-06-21
DE69505095D1 (de)	1998-11-05
CA2164770A1 (en)	1996-06-10
ITRM940797A1 (it)	1996-06-09
EP0719559A1 (de)	1996-07-03

Similar Documents

Publication	Publication Date	Title
ATE171623T1 (de)	1998-10-15	Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser
NO994485L (no)	1999-11-16	Styrt frigivelse av farmasöytiske midler i det fremre kammer i öyet
DE69513902D1 (de)	2000-01-20	Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit
DE69531912D1 (de)	2003-11-20	Vorrichtung zur chirurgischen Behandlung von Presbyopie
DE60022544D1 (de)	2005-10-13	Behandlung von augenerkrankungen
EP0881908A4 (de)	2000-11-02	Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums
FI970703A0 (fi)	1997-02-19	Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine
ATE272987T1 (de)	2004-08-15	Gerät zur behandlung von wachsenden, erweiterten oder missgebildeten blutgefässen
ES2178352T3 (es)	2002-12-16	Derivados de omega-cicloaquil-prostaglandina e1.
BR9808977A (pt)	2000-08-01	Equipamento para modelar a córnea, processos para fazer a ablação de tecido de um olho, e para tratamento de um olho, e, sistema para cirurgia a laser para tratar um olho
DE69930271T8 (de)	2006-12-28	Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE179888T1 (de)	1999-05-15	Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ATE259234T1 (de)	2004-02-15	Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
DE60032594D1 (de)	2007-02-08	Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie
ATE84716T1 (de)	1993-02-15	4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
Reed et al.	1994	An in vivo study of the effect of excimer laser irradiation on degenerate rabbit articular cartilage
DE69811758D1 (de)	2003-04-10	Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
Paulsen et al.	1998	Titanium tetrachloride: an unusual agent with the potential to create severe burns
ATE220065T1 (de)	2002-07-15	Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten
FR2661091B1 (fr)	1994-10-21	Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.
LEE et al.	1996	A clinical experience of phototherapeutic keratectomy for Reis-Bucklers' dystrophy
JPH11140103A (ja)	1999-05-25	脊髄潅流液
ATA196398A (de)	2002-08-15	Corneale maske zur laserchirurgischen abtragung von hornhautgewebe
Çeliköz	2002	Chronic lead poisoning by lead shots and augmentation of facial soft tissue defect with Alloderm dermal graft
BRPI0514954A (pt)	2008-07-01	método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, métodos para descolonizar pelo menos uma porção das cavidades nasais, das narinas anteriores, e/ou da nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade do esÈfago de um indivìduo, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal e/ou na ferida de um indivìduo, para fazer uma composição antimicrobiana

Legal Events

Date	Code	Title	Description
1999-08-15	UEP	Publication of translation of european patent specification